Skip to main content

Table 2 Treatment characteristics

From: The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

Treatment characteristics Arm A (cisplatin 100 mg/m2) Arm B (cisplatin 40 mg/m2) p
N = 26 N = 24
Cisplatin dose (mg/m2)
 Mean (range) 208.5 (100–300) 200.4 (80–280) 0.568
Cisplatin ≥ 200 mg/m2
 No 3 (11.5%) 9 (37.5%) 0.047*
 Yes 23 (88.5%) 15 (62.5%)
RT dose (cGy)
Mean (range) 6477.7 (4820–6600) 6250.0 (1400–7200) 0.361
RT dose ≥ 6000 cGy
 No 2 (7.7%) 2 (8.3%) 1.000
 Yes 24 (92.3%) 22 (91.7%)
RT duration (weeks)
Mean (range) 6.8 (4.6–9.1) 6.6 (1.7–9.0) 0.506
RT duration > 8 weeks
 No 24 (92.3%) 20 (83.3%) 0.409
 Yes 2 (7.7%) 4 (16.7%)
  1. Abbreviations: RT = radiotherapy.
  2. * Statistically significant, p < 0.05.